Skip to main content

Migraine and cerebrovascular disease: still a dangerous connection?

Neurological Sciences volume 39, pages 33–37 (2018)Cite this article

Abstract

Migraine is a common type of headache in young adults, with an estimated prevalence of 4% before puberty and as high as 25% in women by their mid to late 30s. About one third of migraineurs experience transient neurological symptoms known as auras, which characterize a variant known as migraine with aura. Many evidences have shown an increased risk of vascular events in patients affected by migraine, particularly among women and among migraine patients with aura. Potential underlying mechanisms include endothelial dysfunction, hypercoagulability, platelet aggregation, vasospasm, cardiovascular risk factors, paradoxical embolism, spreading depolarization, shared genetic risk, use of non-steroidal anti-inflammatory drugs, and immobilization. The risk of vascular events in migraine patients is also linked by concomitant oral contraception; moreover, the common finding of increased incidence of right to left cardiac shunt in migraine patients might have a pathogenetic role. Finally, many MRI studies in migraine patients, particularly in migraine with aura, have shown subcortical lesions particularly in the cerebellum as a common finding. In this review, we analyzed the more recent findings regarding the topic of migraine as a risk factor in stroke.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Silberstein SD (2004) Migraine. Lancet 363:381–391

    CAS  Article  Google Scholar 

  2. Bigal ME, Lipton RB, Stewart WF (2004) The epidemiology and impact of migraine. Curr Neurol Neurosci Rep 4:98–104. https://doi.org/10.1007/s11910-004-0022-8

    Article  PubMed  Google Scholar 

  3. Rasmussen BK, Jensen R, Schroll et al (1991) Epidemiology of headache in a general population—a prevalence study. J Clin Epidemiol 44:1147–1157. https://doi.org/10.1016/0895-4356(91)90147-2

    CAS  Article  PubMed  Google Scholar 

  4. Kurth T, Winter AC, Eliassen AH, Dushkes R, Mukamal KJ, Rimm EB, Willett WC, Manson JAE, Rexrode KM (2016) Migraine and risk of cardiovascular disease in women: prospective cohort study. BMJ 353:i2610. https://doi.org/10.1136/bmj.i2610

    Article  PubMed  PubMed Central  Google Scholar 

  5. Sacco S, Ornello R, Ripa P, Tiseo C, Degan D, Pistoia F, Carolei A (2015) Migraine and risk of ischaemic heart disease: a systematic review and meta-analysis of observational studies. Eur J Neurol 22:1001–1011. https://doi.org/10.1111/ene.12701

    CAS  Article  PubMed  Google Scholar 

  6. Schürks M, Rist PM, Bigal et al (2009) Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ 339:b3914. https://doi.org/10.1136/bmj.b3914

    Article  PubMed  PubMed Central  Google Scholar 

  7. Tietjen GE (2009) Migraine as a systemic vasculopathy. Cephalalgia 29:987–996. https://doi.org/10.1111/j.1468-2982.2009.01937.x

    CAS  Article  PubMed  Google Scholar 

  8. Lee ST, Chu K, Jung KH et al (2008) Decreased number and function of endothelial progenitor cells in patients with migraine. Neurology 70:1510–1517. https://doi.org/10.1212/01.wnl.0000294329.93565.94

    Article  PubMed  Google Scholar 

  9. Jesurum JT, Fuller CJ, Murinova N, Truva CM, Lucas SM (2012) Aspirin’s effect on platelet inhibition in migraineurs. Headache 52:1207–1218. https://doi.org/10.1111/j.15264610.2012.02143.x

    Article  PubMed  Google Scholar 

  10. Vanmolkot FH, Van Bortel LM, de Hoon JN (2007) Altered arterial function in migraine of recent onset. Neurology 68:1563–1570. https://doi.org/10.1212/01.wnl.0000260964.28393.ed

    Article  PubMed  Google Scholar 

  11. Longoni M, Ferrarese C (2006) Inflammation and excitotoxicity: role in migraine pathogenesis. Neurol Sci 27(Suppl 2):S107–S110

    Article  Google Scholar 

  12. Tzourio C, Tehindrazanarivelo A, Iglesias S, Alperovitch A, Chedru F, d'Anglejan-Chatillon J, Bousser MG (1995) Case-control study of migraine and risk of ischaemic stroke in young women. BMJ 310:830–833

    CAS  Article  Google Scholar 

  13. Carolei A, Marini C, De Matteis G (1996) History of migraine and risk of cerebral ischaemia in young adults. Lancet 347:1503–1506

    CAS  Article  Google Scholar 

  14. Schürks M, Rist PM, Bigal ME et al (2009) Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ 339:b3914

    Article  Google Scholar 

  15. Sacco S, Ornello R, Ripa P, Pistoia F, Carolei A (2013) Migraine and hemorrhagic stroke: a meta-analysis. Stroke 44:3032–3038

    Article  Google Scholar 

  16. Timm FP, Houle TT, Grabitz SD et al (2017) Migraine and risk of perioperative ischemic stroke and hospital readmission: hospital based registry study. BMJ 356:i6635

    Article  Google Scholar 

  17. Adelborg K, Komjáthiné Szépligeti S, Holland-Bill L et al (2018) Migraine and risk of cardiovascular diseases: Danish population based matched cohort study. BMJ 360:k96. https://doi.org/10.1136/bmj.k96

  18. Mahmoud A, Mentias A, Elgendy A (2018) Migraine and the risk of cardiovascular and cerebrovascular events: a meta-analysis of 16 cohort studies including 1 152 407 subjects. BMJ Open 8(3):e020498 Published online 2018 Mar 27

    Article  Google Scholar 

  19. Bigal ME, Kurth T, Hu H, Santanello N, Lipton RB (2009) Migraine and cardiovascular disease: possible mechanisms of interaction. Neurology 72:1864–1871

    CAS  Article  Google Scholar 

  20. Schwerzmann M, Nedeltchev K, Lagger F, Mattle HP, Windecker S, Meier B, Seiler C (2005) Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology 65:1415–1418

    CAS  Article  Google Scholar 

  21. Schmidt M, Christiansen CF, Mehnert F, Rothman KJ, Sorensen HT (2011) Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study. BMJ 343:d3450

    Article  Google Scholar 

  22. Martínez-Sánchez P, Martínez-Martínez M, Fuentes B, Cuesta MV, Cuéllar-Gamboa L, Idrovo-Freire L, Fernández-Dominguez J, Díez-Tejedor E (2011) Migraine and hypercoagulable states in ischemic stroke. Cephalalgia 31:1609–1617

    Article  Google Scholar 

  23. Pietrobon D, Moskowitz MA (2013) Pathophysiology of migraine. Annu Rev Physiol 75:365–391

    CAS  Article  Google Scholar 

  24. Sacco S, Ripa P, Grassi D, Pistoia F, Ornello R, Carolei A, Kurth T (2013) Peripheral vascular dysfunction in migraine: a review. J Headache Pain 14:80

    Article  Google Scholar 

  25. Etminan M, Takkouche B, Isorna FC, Samii A (2005) Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ 330:63

    Article  Google Scholar 

  26. Sacco S, Kurth T (2014) Migraine and the risk for stroke and cardiovascular disease. Curr Cardiol Rep 16:524

    Article  Google Scholar 

  27. MacClellan LR, Giles W, Cole J et al (2007) Probable migraine study. Stroke 38:2438–2445

    Article  Google Scholar 

  28. Norton J, Portet F, Gabelle A, Debette S, Ritchie K, Touchon J, Berr C (2016) Are migraine and non-migrainous headache risk factors for stroke in the elderly? Findings from a 12-year cohort follow-up. Eur J Neurol 23:1463–1470

    CAS  Article  Google Scholar 

  29. Wolf ME, Szabo K, Griebe M, Forster A, Gass A, Hennerici MG, Kern R (2011) Clinical and MRI characteristics of acute migrainous infarction. Neurology 76:1911–1917

    CAS  Article  Google Scholar 

  30. Champaloux SW, Tepper NK, Monsour M, Curtis KM, Whiteman MK, Marchbanks PA, Jamieson DJ (2017) Use of combined hormonal contraceptives among women with migraines and risk of ischemic stroke. Am J Obstet Gynecol 216(5):489.e1–489.e7

    Article  Google Scholar 

  31. Sheikh HU, Pavlovic J, Loder E et al (2018) Risk of stroke associated with use of estrogen containing contraceptives in women with migraine: a systematic review. Headache 58(1):5–21

    Article  Google Scholar 

  32. Kruit MC, van Buchem MA, Hofman PAM et al (2004) Migraine as a risk factor for subclinical brain lesions. JAMA 291:427–434

    CAS  Article  Google Scholar 

  33. Debette S, Markus HS (2010) The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 341:c3666

    Article  Google Scholar 

  34. Lipton RB, Pan J (2004) Is migraine a progressive brain disease? JAMA 291:493–494

    CAS  Article  Google Scholar 

  35. Bashir A, Lipton RB, Ashina S, Ashina M (2013) Migraine and structural changes in the brain: a systematic review and meta-analysis. Neurology 81:1260–1268

    Article  Google Scholar 

  36. Gaist D, Garde E, Blaabjerg M, Nielsen HH, Krøigård T, Østergaard K, Møller HS, Hjelmborg J, Madsen CG, Iversen P, Kyvik KO, Siebner HR, Ashina M (2016) Migraine with aura and risk of silent brain infarcts and white matter hyperintensities: an MRI study. Brain 139:2015–2023

    Article  Google Scholar 

  37. Kruit MC, Launer LJ, Ferrari MD et al (2005) Infarcts in the posterior circulation territory in migraine. the population-based MRI CAMERA study. Brain J Neurol 128:2068–2077

    Article  Google Scholar 

  38. Kurth T, Mohamed S, Maillard P et al (2011) Headache, migraine, and structural brain lesions and function: population based Epidemiology of Vascular Ageing-MRI study. BMJ 342:c7357

    Article  Google Scholar 

  39. Monteith T, Gardener H, Rundek T et al (2014) Migraine, white matter hyperintensities, and subclinical brain infarction in a diverse community: the northern Manhattan study. Stroke J Cereb Circ 45:1830–1832

    CAS  Article  Google Scholar 

  40. Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjögren M, Wallin A, Ader H, Leys D, Pantoni L, Pasquier F, Erkinjuntti T, Scheltens P, European Task Force on Age-Related White Matter Changes (2001) A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 32:1318–1322

    CAS  Article  Google Scholar 

  41. Hu F, Qian ZW (2016) Characteristic analysis of white matter lesions in migraine patients with MRI. Eur Rev Med Pharmacol Sci 20:1032–1036

    CAS  PubMed  Google Scholar 

  42. Schwedt TJ, Demaerschalk BM, Dodick DW (2008) Patent foramen ovale and migraine: a quantitative systematic review. Cephalalgia 28:531–540

    CAS  Article  Google Scholar 

  43. West BH, Noureddin N, Mamzhi Y et al (2018) Frequency of patent foramen ovale and migraine in patients with cryptogenic stroke. Stroke. https://doi.org/10.1161/STROKEAHA.117.020160

    Article  Google Scholar 

  44. Mojadidi MK, Zaman MO, Elgendy IY, Mahmoud AN, Patel NK, Agarwal N, Tobis JM, Meier B (2018) Cryptogenic stroke and patent foramen ovale. J Am Coll Cardiol 71:1035–1043

    Article  Google Scholar 

  45. Mattle HP, Evers S, Hildick-Smith D, Becker WJ, Baumgartner H, Chataway J, Gawel M, Göbel H, Heinze A, Horlick E, Malik I, Ray S, Zermansky A, Findling O, Windecker S, Meier B (2016) Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial. Eur Heart J 37:2029–2036

    Article  Google Scholar 

Download references

Author information

Affiliations

  1. Neurology and Stroke Unit, Department of Neurosciences, Niguarda Ca’ Granda Hospital, Piazza Ospedale Maggiore, 3, 20162, Milan, Italy

    Elio Clemente Agostoni & Marco Longoni

Authors
  1. Elio Clemente Agostoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marco Longoni
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marco Longoni.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical standards

This article does not contain any study with human subjects performed by any of the authors.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Agostoni, E.C., Longoni, M. Migraine and cerebrovascular disease: still a dangerous connection?. Neurol Sci 39, 33–37 (2018). https://doi.org/10.1007/s10072-018-3429-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-018-3429-8

Keywords

  • Migraine
  • Stroke
  • Vascular events
  • Patent foramen ovale
  • Oral contraceptive